These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 22542159)

  • 1. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis.
    Akiyama K; Chen C; Wang D; Xu X; Qu C; Yamaza T; Cai T; Chen W; Sun L; Shi S
    Cell Stem Cell; 2012 May; 10(5):544-55. PubMed ID: 22542159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide promotes immunomodulation of gingiva-derived mesenchymal stem cells via the Fas/FasL coupling pathway.
    Yang R; Yu T; Liu D; Shi S; Zhou Y
    Stem Cell Res Ther; 2018 Mar; 9(1):62. PubMed ID: 29523215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osthole enhances the immunosuppressive effects of bone marrow-derived mesenchymal stem cells by promoting the Fas/FasL system.
    Yu Y; Chen M; Yang S; Shao B; Chen L; Dou L; Gao J; Yang D
    J Cell Mol Med; 2021 May; 25(10):4835-4845. PubMed ID: 33749126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of miRNA‑181a on FasL expression in bone marrow mesenchymal stem cells and its effect on CD4+T lymphocyte apoptosis in estrogen deficiency‑induced osteoporosis.
    Shao B; Fu X; Yu Y; Yang D
    Mol Med Rep; 2018 Jul; 18(1):920-930. PubMed ID: 29845202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression.
    Chen C; Akiyama K; Yamaza T; You YO; Xu X; Li B; Zhao Y; Shi S
    EMBO Mol Med; 2014 Mar; 6(3):322-34. PubMed ID: 24401839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance.
    Shao B; Liao L; Yu Y; Shuai Y; Su X; Jing H; Yang D; Jin Y
    FASEB J; 2015 Sep; 29(9):3935-44. PubMed ID: 26062603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy.
    Yu Y; Liao L; Shao B; Su X; Shuai Y; Wang H; Shang F; Zhou Z; Yang D; Jin Y
    Mol Ther; 2017 Feb; 25(2):480-493. PubMed ID: 28153095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.
    Liu Y; Wang L; Liu S; Liu D; Chen C; Xu X; Chen X; Shi S
    J Dent Res; 2014 Nov; 93(11):1124-32. PubMed ID: 25252877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of bone marrow-derived mesenchymal stem cells in treating colitis through Fas/FasL-mediated immune regulation].
    Yu Y; Shao B; Shuai Y; Shang F; Wang X; Zhou Z; Liao L; Jin Y; Yang D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Oct; 29(10):1028-31. PubMed ID: 24103262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let-7a promotes periodontal bone regeneration of bone marrow mesenchymal stem cell aggregates via the Fas/FasL-autophagy pathway.
    Yang S; Gao J; Chen M; Sun Y; Qiao X; Mao H; Guo L; Yu Y; Yang D
    J Cell Mol Med; 2023 Dec; 27(24):4056-4068. PubMed ID: 37855249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
    Reardon C; Wang A; McKay DM
    J Immunol; 2008 Jun; 180(12):8316-26. PubMed ID: 18523298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant let-7a suppresses the immunomodulatory properties of BMSCs by inhibiting the Fas/FasL system in osteoporosis.
    Liao L; Yu Y; Shao B; Su X; Wang H; Kuang H; Jing H; Shuai Y; Yang D; Jin Y
    FASEB J; 2018 Apr; 32(4):1982-1992. PubMed ID: 29203591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
    Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
    J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR inhibition rescues osteopenia in mice with systemic sclerosis.
    Chen C; Akiyama K; Wang D; Xu X; Li B; Moshaverinia A; Brombacher F; Sun L; Shi S
    J Exp Med; 2015 Jan; 212(1):73-91. PubMed ID: 25534817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
    Mustafa N; Mitxelena J; Infante A; Zenarruzabeitia O; Eriz A; Iglesias-Ara A; Zubiaga AM
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
    Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
    Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
    Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
    Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.